Pathogenesis and pathophysiology of attention-deficit/hyperactivity disorder: From childhood to adulthood

Journal of Neural Transmission

Volumn 115, Issue 2, 2008, Pages 151-153

  Gerlach, M ^a   Deckert, J ^a   Rothenberger, A ^b   Warnke, A ^a  

^a UNIVERSITY OF WÜRZBURG   (Germany)

^b UNIVERSITY OF GÖTTINGEN   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

AMPHETAMINE; BIOLOGICAL FACTOR; METHYLPHENIDATE; NEUROTRANSMITTER; PSYCHOSTIMULANT AGENT;

ANTISOCIAL BEHAVIOR; ANXIETY DISORDER; ATTENTION DEFICIT DISORDER; CHILD PSYCHIATRY; CLINICAL STUDY; COMORBIDITY; CONDUCT DISORDER; DIAGNOSTIC AND STATISTICAL MANUAL OF MENTAL DISORDERS; DISEASE CLASSIFICATION; DISEASE PREDISPOSITION; EDITORIAL; ENVIRONMENTAL FACTOR; GENETIC HETEROGENEITY; GENETIC SUSCEPTIBILITY; HEREDITY; HYPOTHESIS; INTERNATIONAL STATISTICAL CLASSIFICATION OF DISEASES AND RELATED HEALTH PROBLEMS; LEARNING DISORDER; MENTAL DISEASE; MOOD DISORDER; MOTOR COORDINATION DISORDER; MOTOR DYSFUNCTION; NEUROPSYCHOLOGY; OPPOSITIONAL DEFIANT DISORDER; OUTCOME ASSESSMENT; PATHOGENESIS; PATHOPHYSIOLOGY; PERSONALITY DISORDER; PREDICTOR VARIABLE; PRIORITY JOURNAL; RISK FACTOR; SOCIAL INTERACTION; SOCIAL PSYCHOLOGY; TIC;

ADOLESCENT; ATTENTION DEFICIT DISORDER WITH HYPERACTIVITY; CHILD; DISEASE PROGRESSION; HUMANS;

EID: 39549084923     PISSN: 03009564     EISSN: 14351463     Source Type: Journal    
DOI: 10.1007/s00702-007-0870-x     Document Type: Editorial

References (31)

1. Albayrak Ö, Friedel S, Schimmelmann BG, Hinney A, Hebebrand J (2008) Genetic aspects in attention-deficit/hyperactivity disorder. J Neural Transm, this issue, pp 305-315
2. Albrecht B, Rothenberger A, Sergeant J, Tannock R, Uebel H, Banaschewski T (2008) Interference control in attention-deficit/hyperactivity disorder: differential stroop effects for colour-naming and counting. J Neural Transm, this issue, pp 241-247
3. American Psychiatric Association (1992) Diagnostic and statistical manual of mental disorders, 4th edn. Text revision. American Psychiatric Association, Washington, DC
4. T Banaschewski D Brandeis 2007 Annotation: what electrical brain activity tells us about brain function that other techniques cannot tell us - a child psychiatric perspective J Child Psychol Psychiatry 48 415 435
5. T Banaschewski BM Neale A Rothenberger V Roessner 2007 Comorbidity of tic disorders and ADHD - conceptual and methodological considerations Eur Child Adolesc Psychiatry 16 Suppl 1 5 14
6. RA Barkley M Fischer L Smallish K Fletcher 2003 Does the treatment of attention-deficit/hyperactivity disorder with stimulants contribute to drug use/abuse? A 13-year prospective study Pediatrics 111 97 109
7. J Biederman 2003 Pharmacotherapy for attention-deficit/hyperactivity disorder (ADHD) decreases the risk for substance abuse: findings from a longitudinal follow-up of youths with and without ADHD J Clin Psychiatry 64 3 8
8. J Biederman SV Faraone 2005 Attention-deficit/hyperactivity disorder Lancet 366 237 248
9. JK Buitelaar 2005 ADHD: strategies to unravel its genetic architecture J Neural Transm (Suppl) 69 1 17
10. J Buitelaar A Rothenberger 2004 Foreword - ADHD in the political and scientific context Eur Child Adolesc Psychiatry 13 1 6
11. RA El-Zein SZ Abdel-Rahman MJ Hay MS Lopez ML Bondy DL Morris MS Legator 2005 Cytogenetic effects in children treated with methylphenidate Cancer Lett 230 284 291
12. SV Faraone 2005 The scientific foundation for understanding attention-deficit/hyperactivity disorder as a valid psychiatric disorder Eur Child Adolesc Psychiatry 14 1 10
13. C Gillberg IC Gillberg P Rasmussin B Kadesjö H Söderström M Rastam M Johnson A Rothenberger L Niklasson 2004 Co-existing disorders in ADHD - implications for diagnosis and intervention Eur Child Adolesc Psychiatry 13 80 92
14. J Hebebrand A Dempfle K Saar H Thiele B Herpertz-Dahlmann M Linder H Kiefl H Remschmidt U Hemminger A Warnke U Knolker P Heiser S Friedel A Hinney H Schäfer P Nurnberg K Konrad 2006 A genome-wide scan for attention-deficit/hyperactivity disorder in 155 German sib-pairs Mol Psychiatry 11 196 205
15. Huss M, Poustka F, Lehmkuhl G, Lehmkuhl U (2008) Children with ADHD have a reduced long-term risk for nicotine use disorders after treatment with methylphenidate. J Neural Transm, this issue, pp 337-341
16. CP Jacob J Romanos A Dempfle M Heine C Windemuth-Kieselbach A Kruse A Reif S Walitza M Romanos A Strobel B Brocke H Schäfer A Schmidtke J Böning KJ Lesch 2007 Co-morbidity of adult attention-deficit/hyperactivity disorder with focus on personality traits and related disorders in a tertiary referral center Eur Arch Psychiatry Clin Neurosci 257 309 317
17. K Konrad S Neufang GR Hanisch Fink B Herpertz-Dahlmann 2006 Dysfunctional attentional networks in children with attention-deficit/hyperactivity disorder: Evidence from an event-related functional magnetic resonance imaging study Biol Psychiatry 59 643 651
18. A Lumen J Oosterlaan JA Sergeant 2005 The impact of reinforcement contingencies on AD/HD: a review and theoretical appraisal Clin Psychol Rev 25 183 213
19. S Mannuzza RG Klein JL Moulton 2003 Does stimulant treatment place children at risk for adult substance abuse? A controlled, prospective follow-up study J Child Adolesc Psychiatry 13 273 282
20. G Polanczyk MS de Lima BL Horta J Biederman LA Rohde 2007 The worldwide prevalence of ADHD: a systematic review and metaregression analysis Am J Psychiatry 164 942 948
21. V Roessner M Robatzek G Knapp T Banaschewski A Rothenberger 2006 First-onset tics in patients with attention-deficit/hyperactivity disorder: impact of stimulants Dev Med Child Neurol 48 616 621
22. Roessner V, Banaschewski T, Fillmer-Otte A, Becker A, Albrecht B, Sergeant J, Tannock R, Rothenberger A (2008) Color perception deficits in co-existing attention-deficit/hyperactivity disorder and chronic tic disorders. J Neural Transm, this issue, pp 235-239
23. Stopper H, Walitza S, Warnke A, Gerlach M (2008) Brief review of available evidence concerning the potential induction of genomic damage by methylphenidate. J Neural Transm, this issue, pp 333-336
24. E Taylor M Doepfner J Sergeant P Asherson T Banaschewski J Buitelaar D Coghill M Danckaerts A Rothenberger E Sonuga Barke HC Steinhausen A Zuddas 2004 European clinical guidelines for hyperkinetic disorder - first update Eur Child Adolesc Psychiatry 13 7 30
25. A Thapar K Langley P Asherson M Gill 2007 Gene-environment interplay in attention-deficit/hyperactivity disorder and the importance of a developmental perspective Br J Psychiatry 190 1 3
26. Tiffin-Richards M, Hasselhorn M, Woerner W, Rothenberger A, Banaschewski T (2008) Phonological short-term memory and central executive processing in attention-deficit/hyperactivity disorder with/without dyslexia - evidence of cognitive overlap. J Neural Transm, this issue, pp 227-234
27. ME Toplak U Jain R Tannok 2005 Executive and motivational processes in adolescents with attention-deficit/hyperactivity disorder (ADHD) Behav Brain Funct 1 8 DOI: 10.1186/1744-9081-1-8
28. ND Volkow GJ Wang J Newcorn JS Fowler F Telang MV Solanto J Logan C Wong YM Ma JM Swanson K Schulz K Pradhan 2007 Brain dopamine transporter levels in treatment and drug naive adults with ADHD Neuroimage 34 1182 1190
29. S Walitza B Werner M Romanos A Warnke M Gerlach H Stopper 2007 Does methylphenidate cause a cytogenetic effect in children with attention-deficit/ hyperactivity disorder? Environ Health Persp 115 936 940
30. EG Willcut AE Doyle JT Nigg SV Faraone BF Pennington 2005 Validity of the executive function theory of attention-deficit/hyperactivity disorder: a meta-analytic review Biol Psychiatry 57 1336 1346
31. World Health Organization (1992) The ICD-10 classification of mental and behavioural disorders: clinical descriptions and diagnostic guidelines. World Health Organization, Geneva